Japanese optic-spinal MS: Is it MS or neuromyelitis optica and does the answer dictate treatment?

Brian G. Weinshenker; Dean M. Wingerchuk

doi:10.1212/WNL.0b013e3181f88382

Japanese optic-spinal MS: Is it MS or neuromyelitis optica and does the answer dictate treatment?

Brian G. Weinshenker, Dean M. Wingerchuk

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1404-1405
Number of pages	2
Journal	Neurology
Volume	75
Issue number	16
DOIs	https://doi.org/10.1212/WNL.0b013e3181f88382
State	Published - Oct 19 2010

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e3181f88382

Cite this

@article{e575f86cf6a4422fbfbe54dbf9426f2d,

title = "Japanese optic-spinal MS: Is it MS or neuromyelitis optica and does the answer dictate treatment?",

author = "Weinshenker, {Brian G.} and Wingerchuk, {Dean M.}",

note = "Funding Information: Dr. Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of the Canadian Journal of Neurological Sciences and the Turkish Journal of Neurology ; has received research support from Genzyme Corporation and the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd. for a patent re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica. Dr. Wingerchuk serves as a consultant for Novartis and receives research support from Alexion Pharmaceuticals, Inc., Genentech, Inc., Genzyme Corporation, the National Multiple Sclerosis Society, and the Guthy-Jackson Charitable Foundation.",

year = "2010",

month = oct,

day = "19",

doi = "10.1212/WNL.0b013e3181f88382",

language = "English (US)",

volume = "75",

pages = "1404--1405",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Japanese optic-spinal MS

T2 - Is it MS or neuromyelitis optica and does the answer dictate treatment?

AU - Weinshenker, Brian G.

AU - Wingerchuk, Dean M.

N1 - Funding Information: Dr. Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of the Canadian Journal of Neurological Sciences and the Turkish Journal of Neurology ; has received research support from Genzyme Corporation and the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd. for a patent re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica. Dr. Wingerchuk serves as a consultant for Novartis and receives research support from Alexion Pharmaceuticals, Inc., Genentech, Inc., Genzyme Corporation, the National Multiple Sclerosis Society, and the Guthy-Jackson Charitable Foundation.

PY - 2010/10/19

Y1 - 2010/10/19

UR - http://www.scopus.com/inward/record.url?scp=78049494715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049494715&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181f88382

DO - 10.1212/WNL.0b013e3181f88382

M3 - Editorial

C2 - 20826710

AN - SCOPUS:78049494715

SN - 0028-3878

VL - 75

SP - 1404

EP - 1405

JO - Neurology

JF - Neurology

IS - 16

ER -

Japanese optic-spinal MS: Is it MS or neuromyelitis optica and does the answer dictate treatment?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this